SCHEMBL7985702

SCHEMBL7985702

COc1ccc(Cn2cnc3nc(-c4ccccc4)[nH]c(=O)c32)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.50
ALDH1A1 P00352 4/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
KMT2A Q03164 3/20 0.49
GAA P10253 2/20 0.49
NPC1 O15118 1/20 0.48
TNKS O95271 1/20 0.48
GUSB P08236 1/20 0.48
PARP1 P09874 1/20 0.48
CASP3 P42574 1/20 0.48
RAB9A P51151 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
TNKS2 Q9H2K2 1/20 0.48
KDM4E B2RXH2 2/20 0.47
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.47
CYP11B1 P15538 1/20 0.47
CYP11B2 P19099 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985230 0.96 ALDH1A1 (0.53) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7975265 0.89 SMN1; SMN2 (0.61) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7974016 0.89 GAA (0.56) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7974583 0.89 GAA (0.59) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7985355 0.88 GAA (0.56) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7984716 0.88 SMN1; SMN2 (0.53) HPGDALDH1A1SMN1; SMN2KMT2ATNKS
SCHEMBL7991402 0.86 SMN1; SMN2 (0.54) HPGDALDH1A1SMN1; SMN2KMT2ATNKS
SCHEMBL7974476 0.86 GUSB (0.56) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7986518 0.85 SMN1; SMN2 (0.53) HPGDALDH1A1SMN1; SMN2KMT2ATNKS
SCHEMBL7974486 0.85 SMN1; SMN2 (0.50) HPGDALDH1A1SMN1; SMN2KMT2ATNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed